vardenafil "stada" 5 mg filmovertrukne tabletter
stada arzneimittel ag - vardenafilhydrochloridtrihydrat - filmovertrukne tabletter - 5 mg
cetraxal comp 3+0,25 mg/ml øredråber, opløsning
poa pharma scandinavia ab - ciprofloxacin, fluocinolonacetonid - øredråber, opløsning - 3+0,25 mg/ml
cetraxal comp 3+0,25 mg/ml øredråber, opløsning
2care4 aps - ciprofloxacin, fluocinolonacetonid - øredråber, opløsning - 3+0,25 mg/ml
entacapone "mylan" 200 mg filmovertrukne tabletter
mylan ab - entacapon - filmovertrukne tabletter - 200 mg
panodil junior 24 mg/ml oral suspension
haleon denmark aps - paracetamol - oral suspension - 24 mg/ml
pariet 20 mg enterotabletter
eisai ab - rabeprazolnatrium - enterotabletter - 20 mg
carexarit 25 mikrogram overtrukne tabletter
2care4 generics aps - clonidinhydrochlorid - overtrukne tabletter - 25 mikrogram
cetraxal comp 3+0,25 mg/ml øredråber, opløsning
orifarm a/s - ciprofloxacin, fluocinolonacetonid - øredråber, opløsning - 3+0,25 mg/ml
entresto
novartis europharm limited - sacubitril, valsartan - hjertefejl - angiotensin ii antagonister, andre kombinationer, agenter handler på renin-angiotensin systemet - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.
neparvis
novartis europharm limited - sacubitril, valsartan - hjertefejl - agenter, der virker på renin-angiotensinsystemet - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.